H.K. Linn spoke of his reasons behind cancer research for the past 30 years. He lost his mom to cancer at a young age. He said, "no child, nor parent should have to lose someone to cancer". He went on to speak about using frankincense in some preliminary bladder cancer studies and had good results. When he attempted more studies with some other frankincense oils (not Young Living) he did not have the same results. He then was given (he has not rec'd a dime from Young Living) Sacred Frankincense to use for his research and found that it killed bladder cancer cells. He has now just finished a study using the Sacred Frankincense and breast cancer cells. What amazes him and me both is that the compounds within the oil will destroy the cancer cells, but does not harm the healthy cells.
Unlike chemotherapy and radiation that kills both good and bad cells, essential oils can actually determine the difference.
Unfortunately these wonderful discoveries have only been in a petridish. It cost thousands to millions of dollars to do this same research on animals and humans. Usually it is pharmaceutical companies that pay researchers to do this. Pharmaceutical companies are only interested in finding out what compounds in the essential oils such as the Sacred Frankincense kill the cancer cells, that way they can make a synthetic version and sell it to the public as a cancer drug.
H.K. Linn welcomed the enitre group to visit him at his research lab. I would love to take a field trip and learn more.
I have included the latest PubMed Abstract Below.
BMC Complement Altern Med. 2011 Dec 15;11:129. Boswellia sacra essential
oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in
cultured human breast cancer cells. Suhail MM, Wu W, Cao A, Mondalek FG, Fung
KM, Shih PT, Fang YT, Woolley C, Young G, Lin HK. Department of Urology,
University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
ABSTRACT:BACKGROUND: Gum resins obtained from trees of the Burseraceae family
(Boswellia sp.) are important ingredients in incense and perfumes. Extracts
prepared from Boswellia sp. gum resins have been shown to possess
anti-inflammatory and anti-neoplastic effects. Essential oil prepared by
distillation of the gum resin traditionally used for aromatic therapy has also
been shown to have tumor cell-specific anti-proliferative and pro-apoptotic
activities. The objective of this study was to optimize conditions for
preparing Boswellea sacra essential oil with the highest biological activity in
inducing tumor cell-specific cytotoxicity and suppressing aggressive tumor
phenotypes in human breast cancer cells. METHODS: Boswellia sacra essential oil
was prepared from Omani Hougari grade resins through hydrodistillation at 78 or
100 oC for 12 hours. Chemical compositions were identified by gas
chromatography-mass spectrometry; and total boswellic acids contents were
quantified by high-performance liquid chromatography. Boswellia sacra essential
oil-mediated cell viability and death were studied in established human breast
cancer cell lines (T47D, MCF7, MDA-MB-231) and an immortalized normal human
breast cell line (MCF10-2A). Apoptosis was assayed by genomic DNA fragmentation.
Anti-invasive and anti-multicellular tumor properties were evaluated by cellular
network and spheroid formation models, respectively. Western blot analysis was
performed to study Boswellia sacra essential oil-regulated proteins involved in
apoptosis, signaling pathways, and cell cycle regulation. RESULTS: More abundant
high molecular weight compounds, including boswellic acids, were present in
Boswellia sacra essential oil prepared at 100 oC hydrodistillation. All three
human breast cancer cell lines were sensitive to essential oil treatment with
reduced cell viability and elevated cell death, whereas the immortalized normal
human breast cell line was more resistant to essential oil treatment. Boswellia
sacra essential oil hydrodistilled at 100 oC was more potent than the essential
oil prepared at 78 oC in inducing cancer cell death, preventing the cellular
network formation (MDA-MB-231) cells on Matrigel, causing the breakdown of
multicellular tumor spheroids (T47D cells), and regulating molecules involved in
apoptosis, signal transduction, and cell cycle progression. CONCLUSIONS: Similar
to our previous observations in human bladder cancer cells, Boswellia sacra
essential oil induces breast cancer cell-specific cytotoxicity. Suppression of
cellular network formation and disruption of spheroid development of breast
cancer cells by Boswellia sacra essential oil suggest that the essential oil may
be effective for advanced breast cancer. Consistently, the essential oil
represses signaling pathways and cell cycle regulators that have been proposed
as therapeutic targets for breast cancer. Future pre-clinical and clinical
studies are urgently needed to evaluate the safety and efficacy of Boswellia
sacra essential oil as a therapeutic agent for treating breast cancer. PMCID:
PMC3258268 PMID: 22171782 [PubMed - in process]